Home
Conditions
Estrogen Receptor-positive Breast Cancer

Clinical trial condition

Estrogen Receptor-positive Breast Cancer

Explore clinical trials studying Estrogen Receptor-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

28 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Estrogen Receptor-positive Breast Cancer trial results

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

NCT02015559

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +11 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

NCT00602043

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Breast Cancer Diet Intervention Study

NCT03886389

Conditions: Breast Diseases, Breast Neoplasms, Carbohydrate Engorgement, +12 more
Locations: Not specified

View Trial Details

Completed

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

NCT00082810

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

NCT01385280

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

NCT01194440

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

NCT00194779

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +12 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

NCT00407888

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +12 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

NCT00003199

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +13 more
Locations: Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States

View Trial Details

Estrogen Receptor-positive Breast Cancer

Estrogen Receptor-positive Breast Cancer trial results

Related conditions